Melvin K Spigelman - Net Worth and Insider Trading
Melvin K Spigelman Net Worth
The estimated net worth of Melvin K Spigelman is at least $5 Million dollars as of 2024-04-25. Melvin K Spigelman is the Director of The Medicines Co and owns about 53,133 shares of The Medicines Co (MDCO) stock worth over $5 Million. Details can be seen in Melvin K Spigelman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Melvin K Spigelman has not made any transactions after 2018-05-25 and currently still holds the listed stock(s).
Transaction Summary of Melvin K Spigelman
Melvin K Spigelman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Melvin K Spigelman owns 1 companies in total, including AN2 Therapeutics Inc (ANTX) .
Click here to see the complete history of Melvin K Spigelman’s form 4 insider trades.
Insider Ownership Summary of Melvin K Spigelman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ANTX | AN2 Therapeutics Inc | 2022-03-24 | director |
Melvin K Spigelman Latest Holdings Summary
Melvin K Spigelman currently owns a total of 1 stock. Melvin K Spigelman owns 53,133 shares of The Medicines Co (MDCO) as of May 25, 2018, with a value of $5 Million.
Latest Holdings of Melvin K Spigelman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MDCO | The Medicines Co | 2018-05-25 | 53,133 | 84.90 | 4,510,992 |
Holding Weightings of Melvin K Spigelman
Melvin K Spigelman Form 4 Trading Tracker
According to the SEC Form 4 filings, Melvin K Spigelman has made a total of 0 transactions in The Medicines Co (MDCO) over the past 5 years. The most-recent trade in The Medicines Co is the sale of 7,500 shares on May 25, 2018, which brought Melvin K Spigelman around $241,500.
Insider Trading History of Melvin K Spigelman
- 1
Melvin K Spigelman Trading Performance
Melvin K Spigelman Ownership Network
Ownership Network List of Melvin K Spigelman
Ownership Network Relation of Melvin K Spigelman
Melvin K Spigelman Owned Company Details
What does AN2 Therapeutics Inc do?
Who are the key executives at AN2 Therapeutics Inc?
Melvin K Spigelman is the director of AN2 Therapeutics Inc. Other key executives at AN2 Therapeutics Inc include 10 percent owner Adjuvant Global Health Technology Fund De, L.p. , Chief Strategy Officer Kevin Michael Krause , and director & Chief Executive Officer Eric Easom .
AN2 Therapeutics Inc (ANTX) Insider Trades Summary
Over the past 18 months, Melvin K Spigelman made no insider transaction in AN2 Therapeutics Inc (ANTX). Other recent insider transactions involving AN2 Therapeutics Inc (ANTX) include a net sale of 65,764 shares made by Eric Easom , a net sale of 223,880 shares made by Kabeer Aziz , and a net sale of 223,880 shares made by Adjuvant Global Health Technology Fund De, L.p. .
In summary, during the past 3 months, insiders sold 0 shares of AN2 Therapeutics Inc (ANTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 638,618 shares of AN2 Therapeutics Inc (ANTX) were sold and 1,787,778 shares were bought by its insiders, resulting in a net purchase of 1,149,160 shares.
AN2 Therapeutics Inc (ANTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
AN2 Therapeutics Inc Insider Transactions
Melvin K Spigelman Mailing Address
Above is the net worth, insider trading, and ownership report for Melvin K Spigelman. You might contact Melvin K Spigelman via mailing address: The Medicines Company, 8 Campus Drive, Parsippany Nj 07054.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
